Prophylaxis: Influenza Clinical Trial
Official title:
A Phase III, Multicenter, Randomized, Double-Blind, Controlled Study to Evaluate the Safety and Immunogenicity of Two Trivalent Subunit Influenza Vaccines in Healthy Adult Subjects
The purpose of this study is to evaluate the immunologic equivalence of three consecutive
lots of a cell based trivalent subunit influenza vaccine (TIVc), and to assess
immunogenicity, safety and tolerability of the vaccine and an egg based trivalent subunit
influenza vaccine (TIVf).
The study comprised 1 vaccination, 2 clinic visits, 3 reminder calls and 2 blood draws.
Female subjects of childbearing potential were tested for pregnancy before the administration
of the vaccine and included only if using and agreeing to continue to use contraception
during the course of the study.
The total study participation time per subject is about 3 weeks.
n/a